Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Orenstein

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Open Forum Infectious Diseases|May 9, 2022
A Case of <i>Burkholderia pseudomallei</i> Mycotic Aneurysm Linked to Exposure in the Caribbean via Whole-Genome SequencingLisa J Speiser, Sabirah Kasule, Carina M Hall, et al.
BMC Infectious Diseases|March 13, 2022
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trialRobert Orenstein, Erik R Dubberke, Sahil Khanna, et al.
Journal of Travel Medicine|March 8, 2013
A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrheaAbinash Virk, Jayawant Mandrekar, Elie F Berbari, et al.
Open Forum Infectious Diseases|January 24, 2024
A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision LossLisa J Speiser, Alex M Wonnaparhown, Janis Blair, et al.
Scientific Reports|December 1, 2023
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patientsMary J Kasten, Brian D Lahr, Anusha Parisapogu, et al.
Medicine|June 15, 2021
Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illnessJanis E Blair, Ashwini Gotimukul, Fangfang Wang, et al.
The Lancet. Respiratory Medicine|December 5, 2021
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trialZelalem Temesgen, Charles D Burger, Jason Baker, et al.
The Lancet. Neurology|December 1, 2009
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive studyDaniel H Lachance, Vanda A Lennon, Sean J Pittock, et al.
Mayo Clinic Proceedings|December 4, 2022
Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and MortalityTufia C Haddad, Jordan D Coffey, Yihong Deng, et al.
JCO Oncology Practice|June 4, 2021
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19Joshua C Pritchett, Bijan J Borah, Aakash P Desai, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Open Forum Infectious Diseases|May 9, 2022
A Case of <i>Burkholderia pseudomallei</i> Mycotic Aneurysm Linked to Exposure in the Caribbean via Whole-Genome SequencingLisa J Speiser, Sabirah Kasule, Carina M Hall, et al.
BMC Infectious Diseases|March 13, 2022
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trialRobert Orenstein, Erik R Dubberke, Sahil Khanna, et al.
Journal of Travel Medicine|March 8, 2013
A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrheaAbinash Virk, Jayawant Mandrekar, Elie F Berbari, et al.
Open Forum Infectious Diseases|January 24, 2024
A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision LossLisa J Speiser, Alex M Wonnaparhown, Janis Blair, et al.
Scientific Reports|December 1, 2023
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patientsMary J Kasten, Brian D Lahr, Anusha Parisapogu, et al.
Medicine|June 15, 2021
Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illnessJanis E Blair, Ashwini Gotimukul, Fangfang Wang, et al.
The Lancet. Respiratory Medicine|December 5, 2021
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trialZelalem Temesgen, Charles D Burger, Jason Baker, et al.
The Lancet. Neurology|December 1, 2009
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive studyDaniel H Lachance, Vanda A Lennon, Sean J Pittock, et al.
Mayo Clinic Proceedings|December 4, 2022
Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and MortalityTufia C Haddad, Jordan D Coffey, Yihong Deng, et al.
JCO Oncology Practice|June 4, 2021
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19Joshua C Pritchett, Bijan J Borah, Aakash P Desai, et al.
Pageof 9